Old Web
English
Sign In
Acemap
>
authorDetail
>
Philip Kong
Philip Kong
Imperial College London
Immunology
Medicine
Receptor
Internal medicine
Acquired immune system
7
Papers
189
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DEVELOPMENT OF TREM2 AGONISTIC ANTIBODIES TO TREAT ALZHEIMER’S DISEASE
2019
Alzheimers & Dementia
Tina Schwabe
Ilaria Tassi
Herve Rhinn
Adiljan Ibrahim
Philip Kong
Santiago V. Salazar
Seung-Joo Lee
Arnon Rosenthal
Show All
Source
Cite
Save
Citations (0)
Anti‐inflammatory effects of selective glucocorticoid receptor modulators are partially dependent on up‐regulation of dual specificity phosphatase 1
2012
British Journal of Pharmacology
Eugenie Joanny
Qize Ding
Leyi Gong
Philip Kong
Jeremy Saklatvala
Andrew R. Clark
Show All
Source
Cite
Save
Citations (39)
ENU-Based Phenotype-Driven Screening
2012
Methods of Molecular Biology
Vera M. Ripoll
Philip Kong
Paul K. Potter
Show All
Source
Cite
Save
Citations (0)
SIGIRR/TIR‐8 is an inhibitor of toll‐like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis
2010
Arthritis & Rheumatism
Stefan K. Drexler
Philip Kong
Julia J. Inglis
Richard O. Williams
Cecilia Garlanda
Alberto Mantovani
Amir S. Yazdi
Fionula M. Brennan
Marc Feldmann
Brian M. J. Foxwell
Show All
Source
Cite
Save
Citations (43)
Evidence for a DC-specific inhibitory mechanism that depends on MyD88 and SIGIRR
2010
Scandinavian Journal of Immunology
Stefan K. Drexler
Jeremy Wales
Evangelos Andreakos
Philip Kong
Alison Davis
Cecilia Garlanda
Alberto Mantovani
Tracy Hussell
Marc Feldmann
Brian M. J. Foxwell
Show All
Source
Cite
Save
Citations (5)
1